Genomics Company RevoluGen Announces the Appointment of Dr Annalisa Jenkins as Chair
February 23, 2022
London, UK – UK genomics company, RevoluGen Ltd. (RevoluGen or the Company), today announces Dr Annalisa Jenkins, MBBS, FRCP, as Chair of the Board of Directors. Dr Jenkins brings over 30 years of global industry experience to RevoluGen’s board, with expertise in scientific research, genomics, regulatory approval and healthcare systems. She is currently a board [...]
February 23, 2022
BOSTON -- TetraScience, the R&D Data Cloud company, announced today a new collaboration with PerkinElmer's Informatics business to facilitate faster and better scientific decision-making for customers of PerkinElmer's Signals ResearchTM Suite, a leading cloud-based, electronic lab notebook and informatics platform. Around the world today, millions of scientists at leading and emerging scientific research organizations use PerkinElmer's [...]
Lennox announces acquisition of Focus Scientific Solutions, with 30 high-level jobs created
February 23, 2022
Lennox, the Irish scientific and medical solutions partner, has announced the acquisition of Focus Scientific Solutions, the Meath-based laboratory equipment specialists. This strategic investment will support the creation of 30 high-level roles over the next two years and results in Lennox becoming the largest independent Irish company in this sector. Speaking on the announcement, Lennox [...]
Acquisition of Exelead Completed, Plans to Invest More Than € 500 Million in Technology Scale-Up
February 23, 2022
Today the closing of the transaction to acquire Exelead, following regulatory clearances and the fulfillment of other customary closing conditions, for approximately USD 780 million in cash was announced. DARMSTADT, GERMANY Continued investment in Exelead’s capabilities planned over the next ten years Adds to growing global, multi-modality CDMO network of the Life Science business of [...]
BICO has reached a beneficial and sustainable solution with Organovo
February 23, 2022
We are glad to announce that we have reached a settlement with Organovo in which we agreed to resolve all aspects of the disputes between the parties. Organovo and BICO were engaged in several legal disputes regarding Organovo’s patents. Under the new agreement, all civil actions regarding potential infringements and IPRs concerning validity of Organovo’s patents are [...]
February 23, 2022
Fully automated GeoMx RNA workflow reduces hands-on time, allowing users to prepare up to 30 slides in one day with high reproducibility SEATTLE -- NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the release of a fully automated GeoMx® RNA protocol on BOND RX [...]
Dotmatics releases Platform 22.1
February 23, 2022
Latest Platform delivers new capabilities to streamline lab workflows and support customers’ data-informed decision making Electronic Lab Notebook (ELN) integrated with Microsoft Office for the Web for live editing and compatibility across all devices supporting Microsoft Office for the Web Web-based visualization and analytics workspaces extended to include formulations and animal model data, giving researchers [...]
Moderna and Thermo Fisher Scientific Announce Long-Term Strategic Collaboration
February 23, 2022
Agreement to leverage dedicated commercial fill-finish manufacturing capacity in the US for mRNA vaccines and therapies CAMBRIDGE, Mass., & WALTHAM, Mass. -- Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced a 15-year strategic collaboration agreement [...]
PacBio Welcomes Dr. Michael Eberle as Vice President of Computational Biology
February 23, 2022
MENLO PARK, Calif. -- PacBio (Nasdaq: PACB), a leading developer of high-quality, highly accurate sequencing platforms, welcomes Michael Eberle, Ph.D., as Vice President of Computational Biology. Michael will be responsible for leading the company’s bioinformatics and data sciences program to enhance PacBio’s genomic analysis offerings. Michael is a genomics industry veteran with more than 20 years [...]
Semarion raises £2.14 million GBP ($2.89 million USD) seed funding
February 22, 2022
Funding will support recruitment, commercial partnerships, and further development of Semarion’s SemaCyte cell assaying platform, which turns adherent cells into liquid reagents to enable novel drug screening methodologies Investors include Parkwalk Advisors, University of Cambridge Seed Funds, Martlet Capital, and angel investors Cambridge, UK: Semarion Ltd, a University of Cambridge spin-out company from the Cavendish Laboratory [...]

